MDXH MDxHealth SA - Ordinary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Apr 3, 2026
$0.57
· of 52w range
· above low
· to high
$0.4052w low
$5.3352w high
P/E
-5.3
EPS
$-0.67
Revenue
$108M
your badges
52W Range
$0–$5
Analyst Rating
BUY
Price Target
$2
P/E
-5.3
ROE
-2440.4%
Net Profit Margin
-31.1%
Your badge strip is empty — pin a metric anywhere on this page.
MDXH Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.57
P/E
-5.3
EPS
$-0.67
Revenue
$108M
ROE
-2440.4%
52W Range
$0–$5
MDXH Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$108M2019-12-31 → 2025-12-31
EPS$-0.672019-12-31 → 2025-12-31
Free Cash Flow$-3M2021-12-31 → 2025-12-31
Net margin-31.1%2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | MDXH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -5.35Y avg ≈-1.6 | ≈-1.6 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | MDXH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 64.5%5Y avg ≈57.5% | ≈57.5% | · | · | |
| Operating Margin | -13.4%5Y avg ≈-60.5% | ≈-60.5% | · | · | |
| EBITDA Margin | -13.4%5Y avg ≈-59.2% | ≈-59.2% | · | · | |
| Pretax Margin | -32.8%5Y avg ≈-77.1% | ≈-77.1% | · | · | |
| Net Profit Margin | -31.1%5Y avg ≈-76.8% | ≈-76.8% | · | · | |
| ROA | -22.0%5Y avg ≈-36.6% | ≈-36.6% | · | · | |
| ROE | -2440.4%5Y avg ≈-714.8% | ≈-714.8% | · | · | |
| ROIC | 112.9%5Y avg ≈-179.7% | ≈-179.7% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | MDXH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 1.15Y avg ≈2.0 | ≈2.0 | · | · | |
| Quick Ratio | 0.95Y avg ≈0.7 | ≈0.7 | · | · | |
| Interest Coverage | -18.35Y avg ≈-79.5 | ≈-79.5 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | MDXH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.75Y avg ≈0.5 | ≈0.5 | · | · | |
| Inventory Turnover | 7.25Y avg ≈8.4 | ≈8.4 | · | · | |
| Receivables Turnover | 7.45Y avg ≈6.4 | ≈6.4 | · | · | |
| Revenue / Employee | ≈$296.4K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-23.3%
Next Report
Nov 12, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $-0.18 | $-0.20 | 9.0% |
| March 31, 2026 | May 13, 2026 | $-0.17 | $-0.15 | -9.7% |
| Dec. 31, 2025 | $-0.17 | $-0.13 | -32.3% | |
| Sept. 30, 2025 | $-0.16 | $-0.11 | -45.2% | |
| June 30, 2025 | $-0.15 | $-0.13 | -18.6% | |
| March 31, 2025 | $-0.19 | $-0.13 | -43.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $108M | $90M | $70M | $37M | $22M | $18M | |
| Cost of Revenue | $38M | $35M | $26M | $18M | $12M | $10M | |
| Gross Profit | $70M | $55M | $44M | $19M | $11M | $8M | |
| R&D Expense | $10M | $11M | $6M | $5M | $6M | $5M | |
| SG&A Expense | $27M | $23M | $23M | $23M | $14M | $14M | |
| Operating Income | $-14M | $-25M | $-27M | $-38M | $-27M | $-27M | |
| Interest Expense | $786.0K | $384.0K | $355.0K | $314.0K | $229.0K | $89.0K | |
| Interest Income | $2M | $2M | $3M | $241.0K | $11.0K | $4.0K | |
| Pretax Income | $-35M | $-38M | $-43M | $-44M | $-29M | $-29M | |
| Income Tax | $-2M | $382.0K | $1.0K | · | $0 | $0 | |
| Net Income | $-34M | $-38M | $-43M | $-44M | $-29M | $-29M | |
| EPS (Basic) | $-0.67 | $-1.16 | $-1.66 | $-2.78 | $-2.38 | $-0.34 | |
| EPS (Diluted) | $-0.67 | $-1.16 | $-1.66 | $-2.78 | $2.38 | $0.34 | |
| Shares (Basic) | 49,962,852 | 32,859,629 | 25,910,696 | 15,865,817 | 12,193,574 | 83,199,215 | |
| Shares (Diluted) | 49,962,852 | 32,859,629 | 25,910,696 | 15,865,817 | 12,193,574 | 83,199,215 | |
| EBITDA | $-14M | $-25M | $-27M | $-37M | $-26M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $47M | $22M | $16M | $58M | · | |
| Receivables | $15M | $14M | $11M | $9M | $5M | $4M | |
| Inventory | $7M | $4M | $3M | $2M | $2M | $2M | |
| Current Assets | $53M | $67M | $38M | $29M | $67M | $23M | |
| PP&E (Net) | $5M | $4M | $5M | $4M | $2M | $973.0K | |
| Goodwill | $39M | $36M | $36M | $36M | $0 | · | |
| Intangibles | $39M | $41M | $44M | $46M | $3M | $5M | |
| Total Assets | $148M | $157M | $129M | $119M | $75M | $32M | |
| Accounts Payable | $10M | $8M | $9M | $10M | $7M | $5M | |
| Current Liabilities | $50M | $43M | $20M | $18M | $16M | $13M | |
| Total Liabilities | $160M | $142M | $122M | $110M | $28M | $26M | |
| Retained Earnings | $-403M | $-370M | $-331M | $-288M | $-244M | $-215M | |
| Stockholders' Equity | $-12M | $15M | $7M | $9M | $47M | $6M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $965.0K | $880.0K | $2M | |
| Other Non-cash | · | · | · | $9M | $6M | · | |
| Operating Cash Flow | $-2M | $-19M | $-21M | $-34M | $-23M | $-20M | |
| CapEx | $1M | $1M | $3M | $3M | $896.0K | $537.0K | |
| Investing Cash Flow | $-19M | $-2M | $-4M | $-29M | $-885.0K | $-537.0K | |
| Financing Cash Flow | $3M | $45M | $32M | $21M | $66M | $14M | |
| Free Cash Flow | $-3M | $-20M | $-24M | $-37M | $-23M | · | |
| Levered FCF | $-4M | $-20M | $-25M | $-37M | $-24M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 64.5% | 61.2% | 62.6% | 51.9% | 47.5% | · | |
| Operating Margin | -13.4% | -27.5% | -38.9% | -102.3% | -120.7% | · | |
| Net Margin | -31.1% | -42.3% | -61.4% | -118.9% | -130.4% | · | |
| Pretax Margin | -32.8% | -41.9% | -61.4% | -118.9% | -130.4% | · | |
| EBITDA Margin | -13.4% | -27.5% | -38.9% | -99.7% | -116.7% | · | |
| ROA | -22.0% | -26.6% | -34.7% | -45.4% | -54.2% | · | |
| ROE | -2440.4% | -345.3% | -521.7% | -156.7% | -110.0% | · | |
| ROIC | 112.9% | -168.3% | -379.1% | -406.9% | -57.2% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.6 | 2.0 | 1.6 | 4.1 | · | |
| Quick Ratio | 0.9 | 1.4 | 0.6 | 0.5 | 0.3 | · | |
| Interest Coverage | -18.3 | -64.4 | -77.0 | -120.7 | -117.2 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.4 | 0.4 | · | |
| Inventory Turnover | 7.2 | 10.5 | 10.3 | 8.4 | 5.5 | · | |
| Receivables Turnover | 7.4 | 7.1 | 6.9 | 5.3 | 5.3 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | $2.16 | $2.74 | $2.71 | $0.23 | · | · | |
| Cash Flow / Share | $-0.04 | $-0.56 | $-0.83 | $-0.21 | · | · | |
| EPS (TTM) | $-0.67 | $-1.16 | $-1.66 | $-2.78 | $2.38 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $108M | $90M | $70M | $37M | $22M | · | |
| Net Income TTM | $-34M | $-38M | $-43M | $-44M | $-29M | · | |
| P/E | -5.3 | -2.0 | -2.4 | -2.4 | 4.0 | · | |
| Earnings Yield | -18.8% | -48.9% | -42.1% | -42.1% | 25.0% | · |
No quarterly filings for MDXH
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $108M | $90M | $70M | $37M | $22M |
| Gross Margin % | 64.5% | 61.2% | 62.6% | 51.9% | 47.5% |
| Operating Margin % | -13.4% | -27.5% | -38.9% | -102.3% | -120.7% |
| Net Income | $-34M | $-38M | $-43M | $-44M | $-29M |
| Diluted EPS | $-0.67 | $-1.16 | $-1.66 | $-2.78 | $2.38 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.6 | 2.0 | 1.6 | 4.1 |
| Quick Ratio | 0.9 | 1.4 | 0.6 | 0.5 | 0.3 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-3M | $-20M | $-24M | $-37M | $-23M |
Institutional owners (13F) 29 filers · $6.6M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
29
Value held
$6.6M
New positions
5
Exited positions
31
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (-5 vs prior Q) | 31 (+19 vs prior Q) | 7 (-5 vs prior Q) | 5 (-12 vs prior Q) | -132.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Bleichroeder LP | $3,029,544 | 7,378,333 | 45.62% | Shares |
| MVM Partners, LLC | $1,911,206 | 4,700,457 | 28.78% | Shares |
| PERKINS CAPITAL MANAGEMENT INC | $579,722 | 1,411,891 | 8.73% | Shares |
| CITADEL ADVISORS LLC | $209,272 | 509,674 | 3.15% | Shares |
| JANE STREET GROUP, LLC | $206,622 | 503,219 | 3.11% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $133,479 | 325,084 | 2.01% | Shares |
| MILLENNIUM MANAGEMENT LLC | $93,826 | 228,510 | 1.41% | Shares |
| Toroso Investments, LLC | $85,277 | 23,887 | 1.28% | Shares |
| Squarepoint Ops LLC | $82,235 | 200,281 | 1.24% | Shares |
| XTX Topco Ltd | $80,083 | 195,039 | 1.21% | Shares |
| BlackRock, Inc. | $60,384 | 147,063 | 0.91% | Shares |
| Cubist Systematic Strategies, LLC | $53,122 | 11,424 | 0.80% | Shares |
| Point72 Asia (Singapore) Pte. Ltd. | $42,208 | 9,077 | 0.64% | Shares |
| Ground Swell Capital, LLC | $36,180 | 88,114 | 0.54% | Shares |
| Tower Research Capital LLC (TRC) | $15,007 | 36,549 | 0.23% | Shares |
| FAS Wealth Partners, Inc. | $9,290 | 22,625 | 0.14% | Shares |
| Lido Advisors, LLC | $8,316 | 20,253 | 0.13% | Shares |
| Intesa Sanpaolo Wealth Management | $4,106 | 10,000 | 0.06% | Shares |
| MORGAN STANLEY | $313 | 764 | 0.00% | Shares |
| GSA CAPITAL PARTNERS LLP | $198 | 481,985 | 0.00% | Shares |
| WELLS FARGO & COMPANY/MN | $82 | 200 | 0.00% | Shares |
| HRT FINANCIAL LP | $75 | 184,477 | 0.00% | Shares |
| Virtu Financial LLC | $55 | 134,178 | 0.00% | Shares |
| Monetary Solutions, Ltd | $35 | 85 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $12 | 29 | 0.00% | Shares |
| BARCLAYS PLC | $7 | 16 | 0.00% | Shares |
| Cambridge Investment Research Advisors, Inc. | $4 | 10,000 | 0.00% | Shares |
| Farther Finance Advisors, LLC | $4 | 10 | 0.00% | Shares |
| UBS Group AG | $1 | 3 | 0.00% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Bleichroeder LP, Bleichroeder Holdings LLC, Andrew Gundlach | Aug. 14, 2026 | 33.20% | Initial filing | Passive investment | SEC |
| MVM Partners, LLC, MVM V LP, MVM GP (No.5) LP ×3 filings | Oct. 28, 2024 | · | Initial filing | · | SEC |
| Valiance Asset Management Limited, TopMDx Ltd., Valiance Life Sciences Growth Investments GP S.à r.l., Valiance Life Sciences Growth Investments SICAV-SIF ×2 filings | April 14, 2023 | · | Initial filing | · | SEC |
| MVM Partners LLP, MVM V LP, MVM GP (No.5) LP | Dec. 27, 2021 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 10 insiders · 0 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| MVM Partners, LLC | 10% owner | Feb. 3, 2023 P | 45,504,584 | 0 | 0 | $0 |
| Brendan Oconnell | · | June 1, 2026 A | · | 0 | 0 | $0 |
| Joseph Sollee | · | June 1, 2026 A | · | 0 | 0 | $0 |
| Sanford Jay Siegel | · | June 1, 2026 A | · | 0 | 0 | $0 |
| Koen Hoffman | · | June 1, 2026 A | · | 0 | 0 | $0 |
| Hilde Windels | · | June 1, 2026 A | · | 0 | 0 | $0 |
| Michael Holder | · | June 1, 2026 A | · | 0 | 0 | $0 |
| Michael Mcgarrity | · | June 1, 2026 A | · | 0 | 0 | $0 |
| John Bellano | · | June 1, 2026 A | · | 0 | 0 | $0 |
| Don M Hardison | · | June 1, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.01% | 139,346 SH | Sept. 10, 2026 | Daily |
MDXH Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 12 analysts
BUY
Median target
$2.00
+250.3%
3 25.0%
Strong Buy
6 50.0%
Buy
3 25.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-09-30Mean target $1.80 +215.2%
← Below all targets
Current price $0.57
Low$1.00
Mean$1.80
High$3.00
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Apr 3, 2026